Supported by an independent educational grant from Daiichi Sankyo, Inc.
Resource Center
Articles
-
Usual sodium intakes compared with current dietary guidelines --- United States, 2005-2008.
Yoon C, Yang HS, Jeon I, et al. CMAJ. 2011;183:E1073-1084.
-
Usual sodium intakes compared with current dietary guidelines --- United States, 2005-2008.
Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. 2011;60:1413-1417.
-
Heart Disease and Stroke Statistics--2012 Update: A Report From the American Heart Association.
Roger VL, Go AS, Lloyd-Jones DM, et al. Circulation. 2012;125:e2-e220.
-
Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades.
McAlister FA, Wilkins K, Joffres M, et al. CMAJ. 2011;183:1007-1013.
-
Relative effectiveness of clinic and home blood pressure monitoring compared with ambulatory blood pressure monitoring in diagnosis of hypertension: systematic review.
Hodgkinson J, Mant J, Martin U, et al. BMJ. 2011;342:d3621.
-
Hypertension in the elderly.
Gil-Extremera B, Cía-Gómez P. Int J Hypertens. 2012;2012:859176.
-
A novel approach to office blood pressure measurement: 30-minute office blood pressure vs daytime ambulatory blood pressure.
van der Wel MC, Buunk IE, van Weel C, Thien TA, Bakx JC. Ann Fam Med. 2011;9:128-135.
-
Angiotensin receptor blockers and risk of myocardial infarction: meta-analyses and trial sequential analyses of 147 020 patients from randomised trials.
Bangalore S, Kumar S, Wetterslev J, Messerli FH. BMJ. 2011;342:d2234.
-
Common secondary causes of resistant hypertension and rational for treatment.
Faselis C, Doumas M, Papademetriou V. Int J Hypertens. 2011;2011:236239.
-
Effect of pay for performance on the management and outcomes of hypertension in the United Kingdom: interrupted time series study.
Serumaga B, Ross-Degnan D, Avery AJ, et al. BMJ. 2011;342:d108.
-
Sympathetic renal innervation and resistant hypertension.
Campese VM, Ku E, Park J. Int J Hypertens. 2011;2011:814354.
-
Efficacy and safety of valsartan plus hydroclorothiazide for high blood pressure.
Ruvolo A, Mercurio V, Fazio V, et al. World J Cardiol. 2010;2:125-130.
